A calm, plain-English guide for adults who have already received a heart-failure diagnosis and the people helping them.
This source-checked educational guide completed clinical review before public release. It supports understanding and care-team questions; it does not replace individualized diagnosis, treatment, medication, or emergency instructions.
The complete guide remains below. These four paths move directly to the most common needs after diagnosis or discharge.
Start with the 30-second explanation, type, stage, and functional class.
Separate fluid relief from long-term heart protection and selected therapies.
Review weight, symptoms, medicines, activity, and practical barriers.
Separate emergencies from changes that need a prompt care-team call.
One usable mental model before the acronyms, tests, and medication names.
Heart failure does not mean the heart has stopped. It means the heart cannot fill or pump well enough to meet the body's needs without causing problems. Blood and fluid may back up into the lungs or other tissues, while the body may receive less effective blood flow.
A simple way to say it: My heart is still working, but it is having trouble filling, pumping, or keeping up without creating extra pressure or fluid buildup.
A clinical syndrome in which the heart cannot fill or pump effectively enough without producing symptoms, signs, or abnormal pressures.
A commonly used term that emphasizes congestion or fluid buildup. Not every person with heart failure has obvious congestion all the time.
The percentage of blood pushed out of the left ventricle with each squeeze. It is useful, but it is only one part of the diagnosis.
Medication groups supported by professional guidelines for eligible patients. The exact combination depends on the type of heart failure and the person's overall health.
Treatment makes more sense after the patient knows which broad ejection-fraction phenotype the care team is treating.
The main pumping chamber has a weakened squeeze.
Why it matters: This category has a well-established group of heart-protective medications. Diuretics may be added when fluid is building up.
The squeeze percentage may look preserved, but the heart may be stiff, fill poorly, or require abnormally high pressure to fill.
Why it matters: Treatment often focuses on congestion, blood pressure, rhythm problems, kidney and metabolic conditions, and other contributing causes.
The ejection fraction was previously reduced and later improved.
Why it matters: Improvement is meaningful, but it is not automatically the same as cure. The treating team decides whether long-term therapy should continue.
Type, stage, and functional class answer different questions and should not be used interchangeably.
Question answered: How is the heart filling or pumping, and how has ejection fraction changed over time?
Question answered: Where is the person in the heart-failure continuum, from risk through advanced disease?
Question answered: How much do current symptoms limit ordinary physical activity?
These are cause categories—not an online conclusion about one person's heart.
Coronary artery disease, a previous heart attack, or another injury that damages heart muscle.
High blood pressure or conditions that make the heart pump against greater resistance.
A narrowed or leaking valve, congenital heart disease, or another structural abnormality.
Inherited cardiomyopathy, inflammation or infection, pregnancy-related disease, infiltrative disease, alcohol, recreational drugs, or some cancer treatments.
A persistently fast, slow, or irregular rhythm can cause or worsen heart failure in some people.
Diabetes, obesity, kidney disease, sleep apnea, thyroid disease, anemia, and other conditions may contribute to risk, symptoms, or treatment complexity.
A test name is easier to remember when the patient understands the clinical question behind it.
What symptoms, risk factors, congestion signs, rhythm findings, or valve clues are present?
The clinician may listen to the heart and lungs and check neck veins, legs, abdomen, blood pressure, heart rate, and oxygen level.
Kidney, electrolyte, blood-count, thyroid, liver, and heart-stress tests
Is there evidence of heart strain, another cause, or a problem that changes medication safety?
BNP or NT-proBNP can support the evaluation, while kidney function and potassium often influence medication decisions.
ECG or EKG
What is the heart's rhythm and electrical pattern?
It can show a rhythm problem, prior injury pattern, conduction delay, or another clue, but it does not describe pumping strength by itself.
Is the heart enlarged or is fluid visible in the lungs?
A normal X-ray does not answer every heart-failure question, and other lung conditions can also cause abnormal findings.
Heart ultrasound
How well do the chambers squeeze and relax, how do the valves work, and what is the ejection fraction?
This is one of the central tests for classifying heart failure, but the full report matters more than one EF number.
Stress testing, CT, MRI, angiography, hemodynamic testing, or biopsy
Is there blocked blood flow, a specific heart-muscle disease, an abnormal pressure pattern, or another treatable cause?
Not every person needs every test. The suspected cause and the information still missing determine what comes next.
The medication and procedure list becomes easier to understand after the goals are clear.
Reduce extra fluid so breathing, swelling, sleep, and activity may improve.
Lower harmful pressure or hormone signals and make it easier for the heart to move blood.
Use evidence-based treatment to slow progression and reduce the chance of hospitalization or other complications when appropriate.
Address blocked arteries, valve disease, blood pressure, rhythm problems, diabetes, kidney disease, sleep apnea, or another contributor.
Support safe activity, rehabilitation, sleep, nutrition, emotional health, and the person's goals of care.
Each card separates purpose, common examples, monitoring, questions, and the safety boundary.
Common language: Water pills
The job: Help the kidneys remove extra sodium and water through urination.
Reducing congestion can ease swelling and make breathing more comfortable when fluid is building up.
Common language: Blood-vessel and heart-protection medicines
The job: Relax blood vessels and change hormone signals that can increase pressure, fluid retention, and strain on the heart.
In selected heart-failure types, these medicines can protect the heart and reduce worsening over time.
Common language: Heart-rate and heart-protection medicines
The job: Slow the heart and reduce the effect of stress hormones so it can work more efficiently over time.
Certain beta blockers help eligible people with reduced ejection fraction live longer and stay out of the hospital.
Common language: Aldosterone blockers
The job: Block a hormone that promotes sodium retention and harmful changes in the heart.
For eligible patients, these medicines can protect the heart and reduce hospitalization risk.
Common language: Heart-and-kidney protection medicines first developed for diabetes
The job: Change how the kidneys handle glucose and sodium and produce beneficial heart and kidney effects that go beyond blood-sugar control.
Eligible people with heart failure may benefit even if they do not have diabetes, including a lower risk of heart-failure hospitalization.
The job: Address a particular blood-pressure, rhythm, symptom, clotting, or high-risk heart-failure problem.
These medicines are generally used for selected situations rather than as the same default plan for everyone.
Not every person needs a procedure or device.
Angioplasty, bypass surgery, or valve repair or replacement may treat a cause or major contributor when testing supports it.
Monitors for dangerous rhythms and can deliver therapy or a shock. It prevents certain rhythm-related deaths but does not directly remove fluid or make every person feel better.
Coordinates the lower chambers when electrical delay causes them to squeeze out of sync. Only selected people meet the criteria.
Advanced options for selected people with severe heart failure after specialized evaluation.
Can be added at any serious stage to improve symptoms, decision support, and quality of life; it is not limited to the final days of life.
A short operating plan is easier to use than a long lifestyle paragraph.
Use the current medication list and pharmacy labels. Ask why every medicine was started, stopped, held, or changed.
Use the same scale and a consistent time and clothing routine. Follow the weight threshold provided by the care team rather than inventing a dose change.
Small changes can be easier to recognize when they are written down. A caregiver may notice confusion or functional decline first.
Too much sodium can worsen fluid retention, but the correct sodium and fluid limits differ. Ask for actual daily targets instead of assuming everyone needs the same restriction.
Ask what activity is safe now and whether cardiac rehabilitation or a structured walking plan is appropriate.
Some pain medicines, supplements, and salt substitutes can worsen heart failure or interact with treatment. Review them with a clinician or pharmacist.
Tell the team about cost, transportation, pharmacy access, mobility, food, scale access, caregiver capacity, depression, or difficulty following the plan.
The patient's own written action plan controls. These categories organize the conversation.
Do not use the website to decide whether these are safe to watch at home.
Verify: Emergency guidance is anchored to American Heart Association warning-sign education. Local emergency services and the treating team control the response.
Use the number and thresholds in the person's written action plan. If the team cannot be reached and the person is rapidly worsening, seek urgent evaluation.
Verify: American Heart Association patient guidance supports tracking symptom and weight changes, but the care team must provide the exact thresholds and after-hours instructions for the individual patient.
Stable does not mean finished. Continue treatment, monitoring, and scheduled follow-up.
Verify: A written heart-failure action plan from the treating team should replace generic thresholds whenever available.
Professional guidance leads the clinical claims; federal and institutional patient resources support wording and coverage comparison.
Primary professional framework for heart-failure definition, the A-to-D continuum, and reduced, preserved, and improved ejection-fraction categories.
Primary professional guideline supporting staging, treatment goals, medication classes, devices, and disease-management principles.
Current practical pathway supporting the four foundational medication groups and sequencing for eligible people with reduced ejection fraction.
Primary practical pathway for preserved-ejection-fraction diagnosis, comorbidity management, and current treatment framing.
Patient-facing distinction between A-to-D stage and NYHA functional class; last reviewed May 21, 2025.
Patient-facing descriptions and examples of major heart-failure medication groups.
Primary patient-facing support for warning signs, symptom tracking, and common weight-change thresholds.
Supplemental federal lifestyle and living-with information. Because the page was last updated in 2022, it is not used as the authority for current medication or HFpEF treatment claims.
Secondary patient reference used as an external coverage benchmark for tests, medications, devices, home care, and appointment preparation.
Source-checked, nurse-reviewed educational handout. The treating team's written plan controls.
A simple way to say it: My heart is still working, but it is having trouble filling, pumping, or keeping up without creating extra pressure or fluid buildup.
Do not change medicine doses, sodium or fluid limits, or emergency thresholds from this handout. Use the patient-specific written plan.